Detalhe da pesquisa
1.
Integrative clinical genomics of advanced prostate cancer.
Cell
; 161(5): 1215-1228, 2015 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26000489
2.
Integrative Clinical Genomics of Advanced Prostate Cancer.
Cell
; 162(2): 454, 2015 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28843286
3.
Integrin-linked kinase mRNA expression in circulating mononuclear cells as a biomarker of kidney and vascular damage in experimental chronic kidney disease.
Cell Commun Signal
; 22(1): 264, 2024 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38734696
4.
Definition of the Post-COVID syndrome using a symptom-based Post-COVID score in a prospective, multi-center, cross-sectoral cohort of the German National Pandemic Cohort Network (NAPKON).
Infection
; 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587752
5.
Development and Validation of a New BAG-1L-Specific Antibody to Quantify BAG-1L Protein Expression in Advanced Prostate Cancer.
Lab Invest
; 103(11): 100245, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37652207
6.
SARS-CoV-2 infection in chronic kidney disease patients with pre-existing dialysis: description across different pandemic intervals and effect on disease course (mortality).
Infection
; 51(1): 71-81, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35486356
7.
Use and effectiveness of remdesivir for the treatment of patients with covid-19 using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS): a multicentre cohort study.
Infection
; 51(4): 1033-1049, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36763285
8.
Specialized palliative care for hospitalized patients with SARS-CoV-2 infection: an analysis of the LEOSS registry.
Infection
; 51(4): 1119-1126, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36952127
9.
All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort.
Infection
; 50(2): 423-436, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34625912
10.
Genomic correlates of clinical outcome in advanced prostate cancer.
Proc Natl Acad Sci U S A
; 116(23): 11428-11436, 2019 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31061129
11.
[The COVID-19 Pandemic as an Opportunity and Challenge for Registries in Health Services Research: Lessons Learned from the Lean European Open Survey on SARS-CoV-2 Infected Patients (LEOSS)]. / Die COVID-19 Pandemie als Herausforderung und Chance für Register in der Versorgungsforschung: Erfahrungen aus Lean European Open Survey on SARS-CoV-2 Infected Patients (LEOSS).
Gesundheitswesen
; 83(S 01): S45-S53, 2021 Nov.
Artigo
em Alemão
| MEDLINE | ID: mdl-34731893
12.
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial.
Lancet Oncol
; 21(1): 162-174, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31806540
13.
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
N Engl J Med
; 373(18): 1697-708, 2015 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26510020
14.
Correction to: All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort.
Infection
; 50(2): 437-438, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34913136
15.
Differential Lyn-dependence of the SHIP1-deficient mast cell phenotype.
Cell Commun Signal
; 14(1): 12, 2016 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27206658
16.
PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patients.
Br J Cancer
; 113(8): 1225-33, 2015 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26379078
17.
The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial.
Lancet Oncol
; 14(9): 882-92, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23810788
18.
Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial.
Eur J Cancer
; 205: 114103, 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38729054
19.
The protective effect of tumor necrosis factor-alpha inhibitors in COVID-19 in patients with inflammatory rheumatic diseases compared to the general population-A comparison of two German registries.
Front Med (Lausanne)
; 11: 1332716, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38510457
20.
Thio-2 inhibits key signaling pathways required for the development and progression of castration resistant prostate cancer.
Mol Cancer Ther
; 2024 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38412481